- Report
- March 2025
- 294 Pages
Global
From €6628EUR$6,995USD£5,594GBP
- Report
- March 2025
- 312 Pages
Global
From €6628EUR$6,995USD£5,594GBP
- Report
- November 2024
- 175 Pages
Global
From €4738EUR$5,000USD£3,999GBP
- Report
- February 2023
- 159 Pages
Europe
From €3317EUR$3,500USD£2,799GBP
- Report
- March 2023
- 165 Pages
United States
From €3317EUR$3,500USD£2,799GBP
- Report
- September 2022
- 80 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- February 2024
- 115 Pages
Global
From €4501EUR$4,750USD£3,799GBP
Monkeypox is a rare viral infection caused by the monkeypox virus. It is similar to smallpox, but is usually less severe. Infectious disease testing for monkeypox is used to diagnose the infection and to monitor the effectiveness of treatment. Tests used to diagnose monkeypox include PCR, ELISA, and virus isolation. PCR is the most commonly used test, as it is the most sensitive and specific. ELISA is used to detect antibodies to the virus, while virus isolation is used to detect the virus itself.
Infectious disease testing for monkeypox is a small but growing market. Companies in this market include Cepheid, Bio-Rad, and Luminex. Cepheid offers a PCR-based test for the detection of monkeypox virus, while Bio-Rad offers ELISA-based tests. Luminex offers a multiplex PCR-based test for the detection of multiple viruses, including monkeypox. Show Less Read more